Prof Giacomo P. Comi is Associate Professor of Neurology at the University of Milan. He currently holds the positions of Deputy Director of the Centro Dino Ferrari, University of Milan, responsible dell’UOS of Pediatric Neurology at the UOC of Neurology, Fondazione IRCCS Ca ‘Granda Ospedale Maggiore Policlinico, head of the Laboratory of Biochemistry and Genetics, UOC Neurology, Fondazione IRCCS Ca ‘Granda Ospedale Maggiore Policlinico University of Milan.
He obtained the Degree in Medicine and Surgery at the University of Milan, magna cum laude and in 1989 the Specialization board in Neurology. Since 1995/96, he teaches Neuropaediatrics at the Specialization School in Neurology of the University of Milan and then also in neurology and diagnostic biotechnology at the Medical Biotechnology degree course. In 2002 he was nominated Associate Professor in Neurology. In 2002 he was named Vice-Director of the “Dino Ferrari Center for the Neuromuscular and Neurodegenerative disorders” of the University of Milan. In 2014 he qualified for the role of Full Professor of Neurology.
About the scientific activity, in 1985 he worked on the field of mitochondrial encephalomyopathies at the Institute of Clinical Neurology. From 1987 to 1989 he had a visiting fellow at the Neuroimaging Section of National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, U.S.A. From 1989 he returned to the Laboratory of Biochemistry of the Institute of Clinical Neurology and collaborated to research projects onto the pathogenesis of neuromuscular disorders, with particular reference to the muscular dystrophies, metabolic myopathies, mitochondrial encephalomyopathies, Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis. The scientific results of Prof. Comi basic and clinical research have been published in high citation rating peer reviewed journals.
Dr. Corti is the PI of Neural Stem Cell Lab and Associate Professor of Neurology at the University of Milan. She is a Neurologist at the UOC of Neurology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico. She is a researcher in the Neuroscience field, committed to studying the pathogenesis and stem cell/molecular therapies for the treatment of motor neurons diseases, in particular Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular Atrophy (SMA) and Spinal Muscular Atrophy with respiratory distress type I (SMARD1).
Since 1994 and after Medical Degree (1997, magna cum laude), Dr Corti has been involved in the research about neurodegenerative diseases and stem cells in the Department of Neurological Sciences of the University of Milan, where she obtained her education as researcher.
After Board Certification in Neurology, she obtained a PhD in Molecular Medicine at the University of Milan. Since 2004, up to now, she has worked first as research collaborator, then as Assistant Professor and from 2015 as Associate Professor at the University of Milan. In 2014 she obtained the habilitation as Associate Professor and as Full Professor of Neurology. She is a member of the Board of the PhD School of Molecular Medicine and of the Dino Ferrari Center Scientific Committee. The scientific results of Dr. Corti, basic and clinical research have been published in high citation rating peer reviewed journals.
Prof. Vincenzo Silani is the director of the Department of Neurology-Stoke Unit and of the Laboratory of Neuroscience since 2002 and is Professor of Neurology. After having graduated in Medicine, he completed the Residency program in both Neurology and Neurosurgery at the University of Milan Medical School cum laude. He spent a long formative period in the U.S. , at first at Baylor College of Medicine in Houston, then at Columbia University in New York gaining also the ECFMG-USA examination. Being an expert of in vitro human neural cell models, he widely engaged in staminology, transplantology and, more lately, genetics related to neurodegerative disorders. He founded a group (SLAGEN) for the genetic study of ALS/FTD and coordinated different research groups becoming also Co-Chairman of the ALS and Frontotemporal dementia Subspeciality Scientific Panel (SSPs) of the European Academy of Neurology (EAN).
Dr. Yvan Torrente is Director at Stem Cell Laboratory since 2002 and Assistant Professor in Neurology with a special focus on stem cell research for the treatment of neurodegenerative diseases. He received his degree in Medicine and Surgery and his Specialization degree in Neurology at the University of Milan. Right after his degree he carried out an intense research activity abroad, winning a PhD in muscular dystrophies at the Genetic Medicine Laboratory, University of Quebec and later applying for a Ph.D. in Biochemistry at the University of Paris. He then stood out for relevant research studies and the important role as a coordinator for the first Phase I clinical trial for the validation of stem cell transplantation in dystrophic patients. He contributed to the foundation of the Stem Cell Interdepartmental Research Center – UNISTEM and, at the same University of Milan, he is involved in several teaching courses for the Faculties of Medicine and Surgery and Biological and Molecular Sciences. Furthermore, Dr. Torrente is Neurologist at Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan and Staff Neurologist at the Dino Ferrari Center. Since 2012 he is President and Scientific Coordinator at Ystem S.r.l., a biotech company which started out its activity as a spin-off belonging to the University of Milan.
Prof. Roberto Villani
Prof. Luigi Rossi Bernardi
Luigi Rossi Bernardi
Prof. Paolo Cerretelli
Were we are
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano Via Francesco Sforza, 35 Milano
Tel. 02 55033802 - Tel. 02 55033809 email@example.com
Un Paese privo di r&d (impegno sulla ricerca e lo sviluppo) è come una ditta che non ha alcuna progettualità e innovazione, destinata quindi sul medio termine a fallire. Solo gli investimenti, pubblici e privati, potranno salvaguardare proprio il modello assistenziale e le aspettative di ricerca
L’oggetto della nostra ricerca sono appunto la SLA, la SMA e la SMARD1. Quest’ultima è la più rara. Pochi sono i gruppi che la studiano e ancora non si conoscono le cause né sono stati identificati possibili trattamenti. Per la SMA invece, siamo in un periodo storico molto importante
Il 10 settembre scorso si è svolta la decima edizione del Pranzo del Sorriso, una giornata allegra e gioiosa trascorsa tra amici e occasione per fare il punto sugli avanzamenti della ricerca. E' già in programma per il prossimo 23 novembre una serata speciale presso il teatro Le Serre di Grugliasco (TO) per sostenere il progetto Mitofusina2